retatrutide phase 2 trial obesity nejm 2023 triple agonist This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor for — A https://t.co/jNL1GNnHPT #Endocrinology Retatrutide: Triple Agonist for Weight
Description
If you reconstitute a 30 mg vial with sterile water and plan to draw doses over several weeks, you are creating a contamination risk that increases with every injection

But heres the good news: after she stopped the medication and maintained her weight for 3 months, her cycles regulated beautifully to every 28-30 daysthe most regular theyd been since she was a teenager

Vos, and C

J Glob Health
